What are the benefits of taking Vabysmo?

Hello,

Welcome to icliniq.com.

Vabysmo (faricimab-svoa) is a prescription medicine given by injection into the eye and is the first and only FDA-approved treatment designed to block two causes of DME (diabetic macular edema) that are VEGF (vascular endothelial growth factor) and Ang-2§. Other drugs usually block only VEGF. This contributes to its suitability for use in such individuals.

However, do not receive Vabysmo if you:

1. Have an infection in or around your eye.

2. Have active swelling around your eye that may include pain and redness.

3. Are allergic to Vabysmo or any of the ingredients in Vabysmo.

You must be aware of the supervision requirements.

1. Injections such as the one used to treat Vabysmo can result in an eye infection (endophthalmitis), separation of layers of the retina (retinal detachment), or inflammation in the eye, all of which can result in vision loss. If your eye gets red, sensitive to light, or you experience a change or loss of vision, contact your healthcare practitioner immediately.

2. Vabysmo may induce a transient rise in intraocular pressure within 60 minutes after getting the eye injection.

Although not common, Vabysmo patients have experienced significant, sometimes life-threatening, blood clot-related complications such as heart attacks or strokes (thromboembolic events), making monitoring for these occurrences critical.